Core Insights - Novartis will participate in the 8th China International Import Expo, marking its eighth consecutive appearance, emphasizing its commitment to becoming China's most valuable and trusted healthcare partner [1][2] Group 1: Innovation Focus - The "Focus on Innovation" exhibition area will showcase nearly 20 innovative products across four core therapeutic areas: cardiovascular, renal and metabolic, oncology, immunology, and neuroscience [1] - Attendees will have the opportunity to experience award-winning products and new indications for blockbuster drugs, including targeted therapies for cancer and innovative renal treatment pipelines [1] - An immersive interactive experience using advanced spatial computing display technology will allow visitors to explore the journey of innovative drugs within the human body [1] Group 2: Commitment to China - The "Deepening in China" exhibition area will reflect Novartis's century-long relationship with China and its new vision for development in the country [2] - Since 2018, Novartis has aligned its growth strategy with the Import Expo, increasing investments and fostering trust within the industry to contribute sustainably to China's innovative pharmaceutical ecosystem [2] Group 3: Accessibility of Medicine - The "Pharmaceutical Accessibility" exhibition area will highlight Novartis's efforts to enhance medicine accessibility for Chinese patients [2] - The area will showcase collaborations with partners in the pharmaceutical ecosystem, focusing on integrating innovative drugs into the national medical insurance directory and exploring diverse solutions for improving medicine accessibility [2] - A giant curved screen at the exhibition will inspire attendees to envision the future of healthcare through advanced pharmaceutical technologies [2]